Windward Bio Group AG fell 14.2% on Tuesday, November 17, 2026, on 246,200 shares. Headlines around the move:
Windward Bio Group AG (WWB:NASDAQ) closed at $24.29 on November 20, 2026, up 1.15% on the day. The stock trades 28.6% below its 52-week high of $33.99 and 32.3% above its 52-week low of $18.35. Over the past year, it lost 19.2%. Windward Bio Group AG is part of the Health Care sector.
Windward Bio Group is a clinical-stage biotechnology company developing ultra-long-acting antibody medicines for patients with serious respiratory and dermatologic diseases, including asthma, chronic obstructive pulmonary disease, or COPD, and atopic dermatitis. Our product candidates, WIN378 and WIN027, target clinically validated disease pathways and are engineered to remain in the body for extended periods of time, enabling less frequent dosing than currently available treatments. This design feature is combined with additional properties including enhanced target affinity, dual target binding or effector function silencing. We believe our product candidates have the potential to deliver better clinical outcomes while offering the convenience of less frequent dosing than currently available treatments.
Find more stocks like WWB with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.